ReviewFrontiers in medicine2026

Long-read sequencing and next-generation CRISPR editors: a unified pipeline for rare disease precision medicine with ethical and regulatory perspectives.

Anshida Konamveettil Abdul Latheef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.